A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age - Trial PHRR221013-004996
Access comprehensive clinical trial information for PHRR221013-004996 through Pure Global AI's free database. This Phase 3 trial is sponsored by Seqirus UK Limited and is currently Suspended. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
PHRR221013-004996
Phase 3
Suspended
Trial Details
Philippine Health Research Registry • PHRR221013-004996
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age
Study Focus
Interventional
Sponsor & Location
Seqirus UK Limited
Bangladesh;Bulgaria;Colombia;Estonia;Lithuania;Philippines;Poland;Romania;Serbia;Turkey
Timeline & Enrollment
Phase 3
Apr 15, 2024
N/A
ICD-10 Classifications
Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Influenza with other manifestations, seasonal influenza virus identified
Influenza with pneumonia, seasonal influenza virus identified
Influenza due to identified zoonotic or pandemic influenza virus
Data Source
Philippine Health Research Registry
PHRR221013-004996
Non-Device Trial